Gary Brecka

Yeah, last time was terrible.

Yeah, terrible, right.

And no one's really cured of it, but the recurrence rate is high.

But this person is out 15 plus years, I remember, at one point.

Now it's probably much more.

And they would re-review this case in one of the conferences at Johns Hopkins as sort of a learning teaching case.

Now, what happened whereby that patient beat the odds?

Well, it turns out that that patient had an infection after the tumor was resected.

And that infection bed got the standard treatment that we do for an infected area.

The infection was relieved.

In that case, they removed the skull plate, evacuated the bacteria or the infected tumor resection bed, and then bring the patient back in another stage procedure to put the skull plate back on.

The patient did fine from that.

That's sort of a standard complication management strategy in surgery.

Something happened.

I don't know what it is, but we can learn from that case.

Maybe the bacteria ate into the tentacles of the tumors.

Maybe it activated an immune response that fought that cancer even harder and longer than somebody who didn't have that infection.

Maybe it was the evacuation.

Maybe it was some...

molecules or interleukins that were increased from the stress of the second and third operations.